(firstQuint)An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy.

 To assess the tolerability of the up-dosing phase of AVANZ Phleum pratense.

 The frequency of patients with adverse reactions will be the study primary endpoint.

.

 An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy@highlight

The purpose of this study is to assess the tolerability of AVANZ.

